Analytical Performance Research Articles

Design and fabrication of a molecularly imprinted electrochemical sensor with high sensitivity for zearalenone assessment in maize

A highly sensitive and selective molecularly imprinted polymer-based electrochemical sensor was developed for rapid detection of zearalenone (ZEA) in maize samples. The sensor exhibited a wide linear dynamic range from 1 × 10−4 to 1 × 102 ng/mL with an impressive limit of detection of 3.4 × 10−5 ng/mL. It demonstrated excellent selectivity towards ZEA over structurally similar mycotoxins and provided accurate quantification in spiked maize extracts with recoveries ranging from 92 % to 108 % and relative standard deviations under 10 %. Comparative analysis with a conventional HPLC-fluorescence detection method revealed strong correlation (R2 = 0.982) between the two datasets. The proposed imprinted electrochemical sensing platform offers distinct advantages of simplicity, portability, cost-effectiveness, and high analytical performance, making it a promising tool for rapid on-site screening of ZEA contamination in food commodities.

Blood Biomarkers for the Management of Mild Traumatic Brain Injury in Clinical Practice.

Despite the use of validated guidelines in the management of mild traumatic brain injury (mTBI), processes to limit unnecessary brain scans are still not sufficient and need to be improved. The use of blood biomarkers represents a relevant adjunct to identify patients at risk for intracranial injury requiring computed tomography (CT) scan. Biomarkers currently recommended in the management of mTBI in adults and children are discussed in this review. Protein S100 beta (S100B) is the best-documented blood biomarker due to its validation in large observational and interventional studies. Glial fibrillary acidic protein (GFAP) and ubiquitin carboxyterminal hydrolase L-1 (UCH-L1) have also recently demonstrated their usefulness in patients with mTBI. Preanalytical, analytical, and postanalytical performance are presented to aid in their interpretation in clinical practice. Finally, new perspectives on biomarkers and mTBI are discussed. In adults, the inclusion of S100B in Scandinavian and French guidelines has reduced the need for CT scans by at least 30%. S100B has significant potential as a diagnostic biomarker, but limitations include its rapid half-life, which requires blood collection within 3 h of trauma, and its lack of neurospecificity. In 2018, the FDA approved the use of combined determination of GFAP and UCH-L1 to aid in the assessment of mTBI. Since 2022, new French guidelines also recommend the determination of GFAP and UCH-L1 in order to target a larger number of patients (sampling within 12 h post-injury) and optimize the reduction of CT scans. In the future, new cut-offs related to age and promising new biomarkers are expected for both diagnostic and prognostic applications.

Comparison of the analytical sensitivity of COVID-19 rapid antigen tests in Australia and Canada

Rapid testing has become an indispensable strategy to identify the most infectious individuals and prevent the transmission of SARS-CoV-2 in vulnerable populations. As such, COVID-19 rapid antigen tests (RATs) are being manufactured faster than ever yet lack relevant comparative analyses required to inform on absolute analytical sensitivity and performance, limiting end-user ability to accurately compare brands for decision making. To date, more than 1000 different COVID-19 RATs are commercially available in the world, most of which detect the viral nucleocapsid protein (NP). Here, we examine and compare the analytical sensitivity of 26 RATs that are readily available in Canada and/or Australia using two NP reference materials (RMs) – a fluorescent NP-GFP expressed in bacterial cells and NCAP-1 produced in a mammalian expression system. Both RMs generate highly comparable results within each RAT, indicating minimal bias due to differing expression systems and final buffer compositions. However, we demonstrate orders of magnitude differences in analytical sensitivities among distinct RATs, and find little correlation with the median tissue culture infectious dose (TCID50) assay values reported by manufacturers. In addition, two COVID-19/Influenza A&B combination RATs were evaluated with influenza A NP-GFP. Finally, important logistics considerations are discussed regarding the robustness, ease of international shipping and safe use of these reference proteins. Taken together, our data highlight the need for and practicality of readily available, reliable reference proteins for end-users that will ensure that manufacturers maintain batch-to-batch quality and accuracy of RATs. They will aid international public health and government agencies, as well as health and aged care facilities to reliably benchmark and select the best RATs to curb transmission of future SARS-CoV-2 and influenza outbreaks.

Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms.

We compared the clinical and analytical performance of Alzheimer's disease (AD) plasma biomarkers measured using the single-molecule array (Simoa) and Lumipulse platforms. We quantified the plasma levels of amyloid beta 42 (Aβ42), Aβ40, phosphorylated tau (Ptau181), and total tau biomarkers in 81 patients with mild cognitive impairment (MCI), 30 with AD, and 16 with non-AD dementia. We found a strong correlation between the Simoa and Lumipulse methods. Concerning the clinical diagnosis, Simoa Ptau181/Aβ42 (AUC 0.739, 95% CI 0.592-0.887) and Lumipulse Aβ42 and Ptau181/Aβ42 (AUC 0.735, 95% CI 0.589-0.882 and AUC 0.733, 95% CI 0.567-0.900) had the highest discriminating power. However, their power was significantly lower than that of CSF Aβ42/Aβ40, as measured by Lumipulse (AUC 0.879, 95% CI 0.766-0.992). Simoa Ptau181 and Lumipulse Ptau181/Aβ42 were the markers most consistent with the CSF Aβ42/Aβ40 status (AUC 0.801, 95% CI 0.712-0.890 vs. AUC 0.870, 95% CI 0.806-0.934, respectively) at the ≥2.127 and ≥0.084 cut-offs, respectively. The performance of the Simoa and Lumipulse plasma AD assays is weaker than that of CSF AD biomarkers. At present, the analysed AD plasma biomarkers may be useful for screening to reduce the number of lumbar punctures in the clinical setting.

External quality assessments for SARS-CoV-2 genome detection in Austria : Acomparison of the first postpandemic round with results from the pandemic era.

External quality assessment (EQA) schemes provide objective feedback to participating laboratories about the performance of their analytical systems and information about overall regional analytical performance. The EQAs are particularly important during pandemics as they also assess the reliability of individual test results and show opportunities to improve test strategies. With the end of the COVID-19 pandemic, the testing frequency significantly decreased in Austria. Here, we analyzed whether this decrease had an effect on participation and/or performance in SARS-CoV‑2 virus detection EQAs, as compared to the pandemic era. Identical samples were sent to all participating laboratories, and the EQA provider evaluated the agreement of the reported results with defined targets. The EQA was operated under two schemes with identical samples and therefore we analyzed it as asingle EQA round. The performance of testing was reported as true positive ratios, comparing the post-pandemic data to previous rounds. Furthermore, subgroups of participants were analyzed stratified by laboratory type (medical or nonmedical) and the test system format (fully automated or requiring manual steps). While the frequency of false negative results per sample did not change during the 3 years of the pandemic (5.7%, 95% confidence interval [CI] 3.1-8.4%), an average per sample false negative ratio of 4.3% was observed in the first post-pandemic EQA (0%, 1.8%, and 11% for the 3 positive samples included in the test panel, n = 109 test results per sample). In this first post-pandemic EQA medical laboratories (average 0.4% false negative across 3samples, n = 90) and automated test systems (average 1.2% false negative, n = 261) had lower false negative ratios than nonmedical laboratories (22.8%, n = 19) and manual test systems (16.7%, n = 22). These lower average ratios were due to alow concentration sample, where nonmedical laboratories reported 36.8% and manual test systems 54.5% true positive results. Overall ratios of true positive results were below the mean of all results during the pandemic but were similar to the first round of the pandemic. Alower post-pandemic true positive ratio was associated with specific laboratory types and assay formats, particularly for samples with low concentration. The EQAs will continue to monitor the laboratory performance to ensure the same quality of epidemiological data after the pandemic, even if vigilance has decreased.

Highly Reusable Electrochemical Immunosensor for Ultrasensitive Protein Detection

AbstractThe detection and quantification of protein biomarkers in bodily fluids is important for many clinical applications, including disease diagnosis and health monitoring. Current techniques for ultrasensitive protein detection, such as enzyme‐linked immunosorbent assay (ELISA) and electrochemical sensing, involve long incubation times (1.5–3 h) and rely on single‐use sensing electrodes which can be costly and generate excessive waste. This work demonstrates a reusable electrochemical immunosensor employing magnetic nanoparticles (MNPs) and dually labeled gold nanoparticles (AuNPs) for ultrasensitive measurements of protein biomarkers. As proof of concept, this platform is used to detect C‐X‐C motif chemokine ligand 9 (CXCL9), a biomarker associated with kidney transplant rejection, immune nephritis from checkpoint inhibitor therapy, and drug‐associated acute interstitial nephritis, in human urine. The sensor successfully detects CXCL9 at concentrations as low as 27 pg mL−1 within ≈1 h. This immunosensor was also adapted onto a handheld smartphone‐based diagnostic device and used for measurements of CXCL9, which exhibited a lower limit of detection of 65 pg mL−1. Lastly, this work demonstrates that the sensing electrodes can be reused for at least 100 measurements with a negligible loss in analytical performance, reducing the costs and waste associated with electrochemical sensing.

CRISPR/Cas12a-Amplified Aptamer Switch Microplate Assay for Small Molecules.

The presence of small molecule contaminants such as mycotoxins and heavy metals in foods and the environment causes a serious threat to human health and huge economic losses. The development of simple, rapid, sensitive, and on-site methods for small molecule pollutant detection is highly demanded. Here, combining the advantages of structure-switchable aptamer-mediated signal conversion and CRISPR/Cas12a-based signal amplification, we developed a CRISPR/Cas12a-amplified aptamer switch assay on a microplate for sensitive small molecule detection. In this assay, a short DNA strand complementary to the aptamer (cDNA) is immobilized on a microplate, which can capture the aptamer-linked active DNA probe (Apt-acDNA) in the sample solution when the target is absent. With the addition of the Cas12a reporter system, the captured Apt-acDNA probes activate Cas12a to indiscriminately cleave fluorescent DNA substrates, producing a high fluorescence signal. When the target is present, the Apt-acDNA probe specifically binds to the target rather than hybridizing with cDNA on the microplate, and the fluorescence signal is reduced. The analytical performance of our method was demonstrated by the detection of two highly toxic pollutants, aflatoxin B1 (AFB1) and cadmium ion (Cd2+), as examples. The assay exhibited good selectivity and high sensitivity, with detection limits of 31 pM AFB1 and 3.9 nM Cd2+. It also allowed the detection of targets in the actual sample matrix. With the general signal conversion strategy, this method can be used to detect other targets by simply changing the aptamer and cDNA, showing potential practical applications in broad fields.

MOF-derived sandwich-structured dual Z-Scheme Co9S8@ZnIn2S4/CdSe hollow nanocages heterojunction: Target-induced ultrasensitive photoelectrochemical sensing of chlorpyrifos

Exploring efficient photoactive material presents an intriguing opportunity to enhance the analytical performance of photoelectrochemical (PEC) sensor in the environmental analysis. In this work, a sandwich-structured multi-interface Co9S8@ZnIn2S4/CdSe QDs dual Z-Scheme heterojunction, derived from metal-organic framework (MOF), was synthesized as a sensing platform for chlorpyrifos detection, by integrating with enzyme-induced in situ insoluble precipitates strategy. The meticulously designed Co9S8@ZnIn2S4/CdSe QDs exhibited enhanced charge separation efficiency and was proved to be a highly effective sensing platform for the immobilization of biomolecules, attributing to the intrinsic dual Z-Scheme heterojunction and the distinctive hollow structure. The proposed PEC sensing platform combined with enzyme-induced in situ precipitate signal amplification strategy achieved superior performance for sensing of chlorpyrifos (CPF), showing in wide linear range (1.0 pg mL−1–100 ng mL−1), with a limit of detection (0.6 pg mL−1), excellent selectivity, and stability. This work offers valuable insights for the design of novel advanced photoactive materials aimed at detecting environmental pollutants with low level concentration.

Hierarchical Cu3V2O8/Cu6Mo5O18/MXene nanostructures by ultrathin nanosheets for highly sensitive electrochemical detection of organophosphorus pesticides

Transition-metal oxides (TMOs) with hierarchical nanostructures derived from metal organic frameworks (MOFs) were widely applied in electrochemical investigation. In this paper, a rational synthesis strategy of TMOs with specific nanostructures and multiple components was reported. Three-dimensional (3D) CuMoV layered metal hydroxides (CuMoV LDHs) architecture was prepared by mild and facile wet-chemistry process to reshape Cu-MOF surface and realize the self-templated conversion. After thermal annealing, hierarchical CuMoV LDHs were transformed to polynary Cu3V2O8/Cu6Mo5O18 (CMVO) compounds. Based on the electrostatic attraction, CMVO/MXene (CMVON) compounds were assembled by combining the CMVO and few-layer Nb2CTx MXene (f-Nb2C) nanosheets and employed as modified materials on the electrode surface. Benefiting from the superior electronic conductivity, large surface area and shortened ion diffusion pathway, the CMVON hybrids demonstrated excellent electrochemical sensing properties. Upon optimum conditions, the constructed CMVON based AChE biosensor manifested markedly analytical performance with the low limit of detection (LOD) and wide linear ranges for parathion-methyl, malathion, and fenitrothion detection.

Methylation of phase II metabolites of endogenous anabolic androgenic steroids to improve analytical performance.

The study of intact phase II metabolites of endogenous anabolic androgenic steroids (EAAS) gives important information about metabolism and has the potential to improve the detection of doping with testosterone. For analysis with liquid chromatography-mass spectrometry (LC-MS), chemical derivatization at the steroid moiety is a technique to improve the positive ionization efficiency of glucuronidated/sulfated EAAS under collision-induced dissociation (CID) conditions. However, regarding the chromatographic performance, there are still challenges to address, for example, poor peak shape, which is mainly caused by nondefined adsorption in the chromatographic system. Here, we show a novel derivatization technique for the analysis of selected phase II metabolites of EAAS, where the acidic moiety of the glucuronide/sulfate is methylated with different methylation reagents to reduce nondefined adsorption. The methylation reagent trimethylsilyl-diazomethane (TMSD) was preferred over the other tested reagents methyl iodide (MeI) and dimethyl sulfate (DMS). Glucuronidated and sulfated testosterone and epitestosterone were methylated, and their chromatographic performance and CID ion mass spectra obtained in positive ionization mode were investigated. The peak width and peak height were significantly improved for all substances. Methylated testosterone sulfate showed the best results with a 3.5 times narrower peak and 14 times increased intensity compared with underivatized testosterone sulfate. Furthermore, CID ion mass spectra obtained in positive ionization mode showed product ions characteristically for the steroidal backbone for all substances. This preliminary study shows the potential of methylation as a supplementary derivatization technique, which can assist in the development of more sensitive methods due to the improvements in method performance.

Isotopic analysis of uranium at the picogram level with single-shot laser induced breakdown spectroscopy

Uranium was measured by laser induced breakdown spectroscopy (LIBS) with a limit of detection of 1.3 picograms with spectral-peak height as the analytical parameter, which shows an improvement of several orders of magnitude compared to other reports in the literature. The improvement is a result of optimizing the choice of the U analytical line, the system hardware, and the light collection and detection efficiency. The research established properties of U line emission (intensity, signal-to-background ratio, isotopic splitting, and spectral interferences) to select an optimum wavelength for analysis. The samples were mock particles from dried, monodispersed U solution droplets (∼65 pL in volume) deposited on Si wafers. LIBS emission spectra from several 235U-enriched samples were measured to demonstrate the performance for isotopic analysis. For isotopic measurements, two masses for total U, 100 pg and 325 pg, were studied. The 235U: 238U isotopic ratio was obtained by peak fitting the LIBS spectra without requiring calibration with the use of enriched standards. Depending on the total U mass and the 235U enrichment, typical relative standard deviations of the isotopic analysis ranged from several percent down to about 1%. Further, the developed method and the reported analytical performance were all based on single-shot LIBS. Overall, the study highlights the potential of LIBS as a robust and sensitive technique for isotopic analysis of U-containing particles.

Quantitation of three benzimidazole compounds in milk combining effervescence-assisted dispersive liquid–liquid microextraction with electrochemical detection using carbon nanotube-electropolymerized L-DOPA modified sensor

Benzimidazoles constitute a group of compounds known for their applications in pharmacy, agriculture and food industry. In recent decades, researchers have dedicated significant efforts to improving microextraction and detection methods that align with the principles of green analytical chemistry. In the present study, we have devised an effervescence-assisted dispersive liquid–liquid microextraction method and built an electrochemical sensor for the detection of albendazole, fenbendazole, and thiabendazole using GCEs (glassy carbon electrode) modified with multiple walled carbon nanotubes (MWCNTs) and poly (L-Dopa) film, allowing benzimidazole detection in complex matrices such as milk. Optimization of the microextraction procedure and electrochemical performance of the sensor was done by response surface methodology. The electrochemical sensor enabled the detection of albendazole, fenbendazole, and thiabendazole in a range of 0.37 to 100 μg mL−1 with a detection limit ranged between 0.14 to 0.28 μg mL−1. The developed sensor was tested in commercial milk. Results show satisfactory analytical performance, achieving a sensitive and selective quantification, especially considering the complexity of the matrix in which it was applied. The newly created sensor facilitates the simultaneous quantitation of the desired analytes, delivering an exceptionally praiseworthy analytical performance with detection limits lower than most existing methods.

A comparative greenness assessment of chromatographic methods for cilnidipine analysis and its combination

The greenness assessment of analytical methods is an important aspect of green analytical chemistry, which focuses on making analytical procedures eco-friendly and safer. This study conducts a thorough comparative analysis of chromatographic methods utilized in the analysis of Cilnidipine (CLN), a commonly employed antihypertensive medication. The research aims to not only evaluate the analytical performance of different chromatographic techniques but also assess their environmental impact, with a focus on promoting sustainable and eco-friendly practices in pharmaceutical analysis.The greenness profiles of twelve chromatographic methods for CLN and its derivatives were evaluated utilizing multiple assessment metrics including the Green Analytical Procedure Index (GAPI), Analytical GREEness (AGREE), Analytical eco-scale (ESA), Chloroform-oriented Toxicity Estimation (ChlorTox scale), Blue Applicability Grade Index (BAGI), and Red-Green-Blue 12 (RBG 12). By quantifying the environmental implications, the study aims to highlight the importance of adopting greener practices in pharmaceutical analysis. This assessment encompasses considerations such as solvent used, energy consumed, and waste generated by the method. The outcomes of this research contribute valuable insights into the selection of environmentally friendly chromatographic methods for CLN, promoting a balance between analytical efficiency and ecological responsibility in the pharmaceutical field.

Tacrolimus Monitoring in Liver Transplant Recipients, Posttransplant Cholestasis: A Comparative Between 2 Commercial Immunoassays and a Liquid Chromatography-Tandem Mass Spectrometry Method.

Cholestasis commonly occurs after orthotopic liver transplantation. It can be extrahepatic because of mechanical obstruction or intrahepatic because of various causes. During cholestasis episodes, blood concentrations of tacrolimus (TAC) metabolites may increase, potentially affecting TAC concentrations measured by immunoassays. This study aimed to simultaneously evaluate the analytical performance of 2 TAC immunoassays, a quantitative microsphere system (QMS) immunoassay, and chemiluminescence microparticle immunoassay, using liquid chromatography-tandem mass spectrometry (LC-MS/MS) as a reference method in liver transplant recipients. This single-center study included 265 patients who underwent orthotopic liver transplantation. In total, 942 blood samples were collected. TAC trough concentrations were measured using LC-MS/MS and 2 immunoassays in parallel. The plasma concentrations of conjugated bilirubin were measured in all samples. The results were analyzed using Bland-Altman plots and Passing-Bablok regressions. The Bland-Altman plot analysis showed that the TAC QMS immunoassay has a significant bias (+37%) compared with LC-MS/MS, and this bias was higher in patients with cholestasis with hyperbilirubinemia (≤+70% in patients with conjugated bilirubin >150 µmol/L). In comparison, the chemiluminescence microparticle immunoassay showed acceptable analytical performance in patients with hyperbilirubinemia (bias <10%). In agreement with previous findings, the TAC QMS immunoassay showed a positive bias compared with LC-MS/MS. This bias is remarkably high in patients with cholestasis and hyperbilirubinemia, suggesting the cross-reactivity of TAC metabolites with the monoclonal antibody used in the QMS immunoassay.

A tailor-made fluorescent ionic liquid integrating tetrapropylammonium hydroxide with 1-naphathoic acid to construct a dual-emitting fluoroprobe for sensing hydroquinone in environmental waters

Herein, a dual-emitting fluoroprobe was pioneered for the sensitive and selective detection of hydroquinone (HQ) in environmental waters, which was based on integration of a tailor-made fluorescent ionic liquid ([TBAOH][NA]) with Eu3+ (([TBAOH][NA]/Eu3+). HQ could substantially enhance the 365-nm fluorescence intensity (FI365) of [TBAOH][NA]/Eu3+, whereas no prominent variation ocurred in FI615. After HQ binding with [TBAOH][NA], the electronic structure of S1 was completely pi-pi*, and the orbital overlap of the latter was much higher, thereby promoting photon transitions. After some key factors were optimized using a central-composite-design (CCD) approach, this fluroprobe provided a linear response from 0.5 to 100 μM and detection limit of 0.15 μM for HQ assay, which was comparable to analytical performance by conventional HPLC-DAD analysis. Overall, the prominent advantages of as-developed fluoroprobe lie in two aspects: (1) Employing the ratio of two well-resolved emission and significantly differential responses to HQ greatly enhance sensitivity and accuracy through a self-calibration system; and (2) [TBAOH][NA] has not only the superiority of “green solvent” like conventional ionic liquids, but also possesses strong luminescence signal owing to introducing 1-naphathoic acid as an anion into tetrapropylammonium hydroxide. Consequently, this dual-emitting fluoroprobe is endowed with great potential in on-site and outdoor HQ monitoring.

Development and performance of NLISA for C-reactive protein detection based on Prussian blue nanoparticle conjugates.

Prussian blue nanoparticles (PBNPs), also called nanozymes, are very attractive as an alternative to horseradish peroxidase in immunoassay development due to their simple and low-cost synthesis, stability and high catalytic activity. Today, there is a method for highly effective PBNP synthesis based on the reduction of an FeCl3/K3[Fe(CN)6] mixture by hydrogen peroxide. However, there is a lack of research showcasing the use of these highly effective PBNPs for specific target detection in clinical settings, as well as a lack of comprehensive comparisons with conventional methods. To address this gap, we prepared diagnostic reagents based on highly effective PBNPs by modifying them using gelatin and attaching anti-C-reactive protein (CRP) monoclonal antibodies through cross-linking with glutaraldehyde. As a result, a solid-phase colorimetric immunoassay in a sandwich format (nanozyme-linked immunosorbent assay [NLISA]) using highly effective PBNPs as a label for CRP detection has been demonstrated for the first time. The assay demonstrated a detection limit of 21.8pg/mL, along with acceptable selectivity, precision (CV < 25%) and accuracy (the recovery index was within acceptable limits (75-125%) for LLOQ /ULOQ range. The analytical performance of this method is on par with sensitive assays developed in the last 5 years. Notably, the results obtained from NLISA align with those from an immunofluorescence assay conducted by a certified clinical laboratory. Furthermore, this study underscores the technological challenges involved in constructing an analysis that necessitate further exploration.

In vivo profiling of phytocannabinoids in Cannabis spp. varieties via SPME-LC-MS analysis

BackgroundIn vivo solid-phase microextraction (SPME) is a minimally invasive, non-exhaustive sample-preparation technique that facilitates the direct isolation of low molecular weight compounds from biological matrices in living systems. This technique is especially useful for the analysis of phytocannabinoids (PCs) in plant material, both for forensic purposes and for monitoring the PC content in growing Cannabis spp. plants. In contrast to traditional extraction techniques, in vivo SPME enables continuous tracking of the changes in the level of PCs during plant growth without the need for plant material collection. In this study, in vivo SPME utilizing biocompatible C18 probes and liquid-chromatography coupled to quadrupole time-of flight mass spectrometry (LC-Q-TOF-MS) is proposed as a novel strategy for the extraction and analysis of the acidic forms of five PCs in growing medicinal cannabis plants. ResultsThe SPME method was optimized by testing various parameters, including the extraction phase (coating), extraction and desorption times, and the extraction temperature. The proposed method was validated with satisfactory analytical performance regarding linearity (10–3000 ng/mL), limits of quantification, and precision (relative standard deviations below 5.5 %). The proposed method was then successfully applied for the isolation of five acidic forms of PCs, which are main components of growing medicinal cannabis plants. As a proof-of-concept, SPME probes were statically inserted into the inflorescences of two varieties of Cannabis spp. plants (i.e., CBD-dominant and Δ9-THC-dominant) cultivated under controlled conditions for 30 min extraction of tetrahydrocannabinolic acid (Δ9-THCA), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), cannabiviarinic acid (CBVA), and tetrahydrocannabivarinic acid (THCVA). Significance and noveltyThe results confirmed that the developed SPME-LC-Q-TOF-MS method is a precise and efficient tool that enables direct and rapid isolation and analysis of PCs under in vivo conditions. The proposed methodology is highly appealing option for monitoring the metabolic pathways and compositions of multiple PCs in medicinal cannabis at different stages of plant growth.

DNA-functionalized cryogel based colorimetric biosensor for sensitive on-site detection of aflatoxin B1 in food samples

Hydrogel biosensors present numerous advantages in food safety analysis owing to their remarkable biocompatibility, cargo-loading capabilities and optical properties. However, the current drawbacks (slow target responsiveness and poor mechanical strength) restricted their further utilization at on-site detection of targets. To address these challenges, a DNA-functionalized cryogel with hierarchical pore structures is constructed to improve the reaction rate and the robustness of hydrogel biosensor. During cryogel preparation, ice crystals serve as templates, shaping interconnected hierarchical microporous structures to enhance mass transfer for faster responses. Meanwhile, in the non-freezing zone, concentrated monomers create a dense cross-linked network, strengthening cryogel matrix strength. Accordingly, a colorimetric biosensor based on DNA cryogel has been developed as a proof of concept for rapid detection of aflatoxin B1 (AFB1) in food samples, and an excellent analytical performance was obtained under the optimized conditions with a low detection limit (1 nM), broad detection range (5–100 nM), satisfactory accuracy and precision (recoveries, 81.2–112.6 %; CV, 2.75–5.53 %). Furthermore, by integrating with a smartphone sensing platform, a portable device was created for rapid on-site measurement of target within 45 min, which provided some insight for hydrogel biosensors design.

Using analytical performance specifications in a medical laboratory.

Analytical performance specifications (APS) are used for the quantitative assessment of assay analytical performance, with the aim of providing information appropriate for clinical care of patients. One of the major locations where APS are used is in the routine clinical laboratory. These may be used to assess and monitor assays in a range of settings including method selection, method verification or validation, external quality assurance, internal quality control and assessment of measurement uncertainty. The aspects of assays that may be assessed include imprecision, bias, selectivity, sample type, analyte stability and interferences. This paper reviews the practical use of APS in a routine clinical laboratory, using the laboratory I supervise as an example.

Smartphone-interfaced flow injection amperometric system for enzyme-free glucose detection using a palladium-PANI/carbon microsphere@carbon nanotubes modified electrode

Integrating a flow injection system with an electrochemical sensor controlled by a smartphone enables rapid, precise real-time monitoring and reduces analyte consumption, contamination and costs. An enzyme-free electrochemical sensor is presented for the monitoring of glucose, an important indicator of diabetes. The sensor integrates a smartphone and a flow injection amperometric system. The flow cell is fabricated from acrylic plastic and includes an electrochemical three-electrode cell that comprises a working electrode modified with a catalyst of palladium-polyaniline/carbon microspheres@carbon nanotubes (Pd-PANI/CM@CNTs/E) for the detection of glucose oxidation. In the optimal condition, the proposed system produced good analytical performances. The sensor determined glucose linearly in a range from 0.020 to 100 mM, with a sensitivity of 51.51 μA mM−1 cm−2, and a detection limit (LOD) of 0.0071 mM. The developed system also exhibited good repeatability, reproducibility, operational stability, and anti-interference properties, and accurately determined glucose levels in real human serum samples. This sensing platform provides an alternative tool for the development of a continuous glucose monitor system for clinical applications.